We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Palisade Bio Inc is a clinical-stage biopharma company. It is advancing oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio's innovative lead asset, LB1148, is a Phase 3-ready protease inhibitor wi... Palisade Bio Inc is a clinical-stage biopharma company. It is advancing oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio's innovative lead asset, LB1148, is a Phase 3-ready protease inhibitor with the potential to both reduce abdominal adhesions and help restore bowel function following surgery. Show more
Carlsbad, CA, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Β Palisade Bio, Inc. (Nasdaq: PALI) (βPalisade,β βPalisade Bioβ or the βCompanyβ), a clinical-stage biopharmaceutical company focused on developing...
Carlsbad, CA, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc, (Nasdaq: PALI) (βPalisade,β βPalisade Bioβ or the βCompanyβ), a clinical-stage biopharmaceutical company focused on...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.12 | -6.59340659341 | 1.82 | 1.86 | 1.67 | 114083 | 1.74594292 | CS |
4 | -0.8 | -32 | 2.5 | 3.3 | 1.38 | 3854391 | 2.31024194 | CS |
12 | -1.86 | -52.2471910112 | 3.56 | 4.318 | 1.38 | 1344546 | 2.34607642 | CS |
26 | -2.82 | -62.389380531 | 4.52 | 4.7871 | 1.38 | 646414 | 2.42619037 | CS |
52 | -7.255 | -81.0161920715 | 8.955 | 22.35 | 1.38 | 1251918 | 8.94074999 | CS |
156 | -1250.8 | -99.8642714571 | 1252.5 | 1260 | 1.38 | 1995789 | 126.29737605 | CS |
260 | -6748.3 | -99.9748148148 | 6750 | 8182.5 | 1.38 | 1760552 | 328.59364052 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions